SCHEMBL23138147

SCHEMBL23138147

CN(C)c1ccc2c(c1Cl)S(C)(C)c1c(ccc(N(C)C)c1Cl)C2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NSD2 O96028 1/20 0.36
EGFR P00533 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
POLB P06746 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 3/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PTK2B Q14289 1/20 0.33
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23138146 0.75 ALDH1A1 (0.36) MAPK1ALDH1A1LMNAL3MBTL1NSD2
SCHEMBL7386352 0.71 RET (0.39) MAPK1LMNATDP1POLBNPSR1
SCHEMBL2443752 0.68 GAA (0.46) MAPK1ALDH1A1LMNAL3MBTL1MAPT
SCHEMBL8927868 0.61 CYP3A4 (0.40) MAPK1ALDH1A1LMNAL3MBTL1NSD2
SCHEMBL18984670 0.60 ALDH1A1 (0.50) MAPK1ALDH1A1LMNAL3MBTL1NSD2
SCHEMBL3786708 0.60 GAA (0.52) MAPK1ALDH1A1LMNAL3MBTL1NSD2
SCHEMBL18874615 0.59 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPTTDP1NPSR1
SCHEMBL12316533 0.59 GFER (0.37) MAPK1ALDH1A1POLBNPSR1BLM
SCHEMBL23116593 0.58 ATP1A1 (0.40) MAPK1ALDH1A1LMNAMAPTPOLB
SCHEMBL6790445 0.58 GAA (0.42) MAPK1L3MBTL1NSD2MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11560365-B2 Non-fluorescent rhodamines THE UNIVERSITY OF TOKYO (JP) 2023-01-24 US disclosed
US-20210087160-A1 NOVEL NON-FLUORESCENT RHODAMINES THE UNIVERSITY OF TOKYO (JP) 2021-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210087160-A1 NOVEL NON-FLUORESCENT RHODAMINES QTRT1, QTRT2, NONO MAPK1 3022/4885ALDH1A1 4506/4885LMNA 2033/4885
US-11560365-B2 Non-fluorescent rhodamines QTRT1, QTRT2, NONO MAPK1 3042/4885ALDH1A1 4441/4885LMNA 1831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.